Back to News
Market Impact: 0.18
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION
Source: GlobeNewswire
Insider TransactionsManagement & GovernanceHealthcare & Biotech
Hofseth BioCare board member and primary insider Christoph Baldegger purchased 2.5 million HBC shares in an off-market transaction at an average price of NOK 1.13 per share on 17 September 2026. The NOK 2.83 million purchase signals insider confidence but is unlikely to have broad market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
HBC0.45
More News
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Adeia earnings on deck: Can diversification offset Pay-TV woes?
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution
- Sam Altman makes surprise South Korea visit as OpenAI builds on chip partnerships
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)
- How to Extract KPIs From Earnings Transcripts With AI